New combination therapy shows promise in metastatic pancreatic cancer

Results from an early-stage clinical trial, published in Nature Communications, showed encouraging outcomes among patients with newly diagnosed cancer whose tumors had spread to distant organs. Most strikingly, one patient experienced a pathologic complete response—meaning no viable cancer cells could be found—and remains cancer-free for more than two years without further treatment. These findings offer an important signal that a new approach may be able to overcome one of the disease's greatest challenges: its resistance to immunotherapy.